New MRI technique could help men with prostate cancer avoid unnecessary treatment

NCT ID NCT03648359

ENROLLING_BY_INVITATION Diagnosis Sponsor: Herlev Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study is testing whether a special type of MRI (multiparametric MRI) can better identify which men with low-risk prostate cancer can safely delay treatment. About 200 men already on active surveillance will receive the MRI, and if suspicious areas are found, they will get additional biopsies. The goal is to see if the MRI helps doctors decide when to switch from monitoring to active treatment, potentially reducing overtreatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: multiparametric MRI (imaging procedure)
What this could lead to: If successful, this could help doctors more accurately decide which low-risk prostate cancer patients can safely avoid immediate treatment and which need active therapy.
What could go wrong: This is an observational study, not a treatment trial. MRI may miss some cancers or lead to unnecessary biopsies, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOW-RISK LOCALIZED PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate carcinoma prostate neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATIC NEOPLASMS

Contacts and locations

Locations

Department of Urology, Herlev University Hospital Herlev

Herlev, 2730, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.